About one in eight adults in the United States has tried or currently uses a GLP-1 medication, and a quarter of those users cite weight loss as their main goal.
Positron is committed to expanding the cardiac and oncology PET modality by delivering the best technology and value to imaging specialists and will continue to advance its technology through its ...
Addiction corrupts the ability to make choices.Addiction brings about changes in the brain, but those changes do not reflect a pathological process. The pathways to addiction can be difficult to ...